Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYNJ2 | O15056 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.57 |
| ▸ | ACHE | P22303 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | APP | P05067 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | RECQL | P46063 | 2/20 | 0.54 |
| ▸ | PKM | P14618 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | ABL1 | P00519 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7718116 | 0.90 | CA12 (0.59) | SYNJ2CYP3A4ACHEMAPTMEN1 | |
| SCHEMBL1614609 | 0.86 | CYP3A4 (0.73) | CYP3A4MAPTMEN1KMT2AMAPK1 | |
| SCHEMBL29757572 | 0.84 | CYP3A4 (0.76) | SYNJ2CYP3A4ACHEMAPTMEN1 | |
| SCHEMBL1937218 | 0.84 | CYP3A4 (0.76) | SYNJ2CYP3A4ACHEMAPTMEN1 | |
| SCHEMBL22658267 | 0.84 | SYNJ2 (0.69) | SYNJ2CYP3A4MAPTMEN1KMT2A | |
| SCHEMBL10823716 | 0.82 | CYP3A4 (0.60) | SYNJ2CYP3A4ACHEMAPTMEN1 | |
| SCHEMBL11645189 | 0.80 | CYP3A4 (0.52) | SYNJ2CYP3A4ACHEMAPTMEN1 | |
| 3,4,5-Trimethoxybenzoic Acid SCHEMBL28170224 | 0.79 | TPMT (0.68) | SYNJ2CYP3A4ACHEMAPTSMN1; SMN2 | |
| SCHEMBL5603951 | 0.78 | CYP3A4 (0.54) | SYNJ2CYP3A4ACHEMAPTMEN1 | |
| SCHEMBL31233350 | 0.78 | MAPT (0.58) | SYNJ2CYP3A4MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230296984-A1 | EUV RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2023-09-21 | — | — | US | disclosed |
| US-20230296984-A1 | EUV RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2023-09-21 | — | — | US | disclosed |
| US-20220216411-A1 | BORON-CONTAINING CYCLIC EMISSIVE COMPOUNDS AND COLOR CONVERSION FILM CONTAINING THE SAME | NITTO DENKO CORP (JP) | 2022-07-07 | — | — | US | disclosed |
| US-20210397090-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION AND METHOD FOR FORMING RESIST PATTERN USING THE SAME | NISSAN CHEMICAL CORPORATION (JP) | 2021-12-23 | — | — | US | disclosed |
| CN-108250482-B | Additive capable of improving dynamic mechanical property of rubber and preparation and application thereof | 同济大学 | 2019-12-27 | — | — | CN | disclosed |
| WO-2017051020-A1 | DYE COMPOSITION COMPRISING A RESORCINOL-BASED COUPLER AND AN OXIDATION BASE | L'OREAL (FR) | 2017-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220216411-A1 | BORON-CONTAINING CYCLIC EMISSIVE COMPOUNDS AND COLOR CONVERSION FILM CONTAINING THE SAME | BLVRB, CLTB, CRY1 | SYNJ2 2436/4885CYP3A4 1968/4885ACHE 3638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.